A judge that tossed two shareholder class actions against the Commonwealth Bank of Australia has found the bank did not have to alert investors to the possibility of AUSTRAC proceedings, saying investors did not expect to be apprised of the “toings and froings” of regulatory investigations.
The High Court has been asked to overturn a NSW Court of Appeal decision finding it had no power to exclude unregistered group members from a settlement, which conflicted with Federal Court precedent, hearing the divergence of the important issue âcan only be resolved by the High Courtâ.
A judge has expressed concerns about the plaintiffâs proposed group costs order rate in a shareholder class action against fleet management company FleetPartners, saying the purpose of the GCO regime was to lower costs to group members.
The funder behind two class actions against Uber, which have settled for $272 million, stands to make a tidy sum if the settlement holds up at a court approval hearing.
Two class actions have failed to convince a judge that the Commonwealth Bank of Australia’s money laundering compliance failure which led to a $700 million penalty was “law breaking on a grand scale” that should have been disclosed to the market, the latest shareholder case to flop after being taken to trial.
Convenience chain 7-Eleven has defeated Seven Network’s challenge to its bid to trade mark ‘7-Select’ for a new brand of products targeting younger shoppers, with an IP Australia delegate finding consumer confusion was not likely.
Japanese company Hitachi has hit back at a lawsuit filed by the entity in charge of a $511 million waste-to-energy plant in Western Australia which accuses Acciona of withholding $38.6 million in bank guarantees, denying any joint liability with the Spanish infrastructure giant.
A judge has signed off on a $16 million settlement in a class action against Dixon Advisory, but the funder of a competing case that was stayed after losing a beauty parade has earned a fragment of the $1 million it sought from the resolution sum.
After a seven-year legal battle, a court has upheld the validity of Neurim Pharmaceuticalâs patent for insomnia drug Circadin and ruled two generic drug companies infringed the intellectual property.
The entity in charge of a $511 million waste-to-energy plant south of Perth has filed a second lawsuit against Acciona, accusing the Spanish infrastructure giant of withholding $38.6 million in bank guarantees to use as leverage in unrelated disputes about the troubled project.